FWIW ....7W.... my opinion is that when a company is the target of the biggest unrelenting negative manipulation in the history of bio (which is known for this type of activity) it not only scares investors off (and kills a big part of the positive mood with investors) but it scares bio company decision makers away or makes them want to wait much further than they otherwise would have, from making deals...
IMO as long as the product gets to market to help patients ,as quick as possible, this peripheral activity does not matter that much, especially in the long term, as a partnership ,may/could actually slow down 273 getting to market .... Unless a partnership is good for patients it should be refused....
News 
Market Data 
Discover 
